Literature DB >> 6321990

Association of Ureaplasma urealyticum in the placenta with perinatal morbidity and mortality.

R B Kundsin, S G Driscoll, R R Monson, C Yeh, S A Biano, W D Cochran.   

Abstract

We investigated the presence of ureaplasmas, mycoplasmas, chlamydiae, fungi, aerobic and anaerobic bacteria, and cytomegalovirus in fetal membranes and evaluated their association with perinatal morbidity and mortality. We cultured 801 placentas from three groups of subjects (144 who died in the perinatal period, 452 neonates admitted to the intensive-care unit, and 205 controls). Ureaplasma urealyticum, Mycoplasma hominis, or both were isolated from 21 per cent of placentas of premature and term infants who died in the perinatal period, 25 per cent of those admitted to intensive care, and 11 per cent of controls. Gestational age and birth weight were inversely related to isolation of ureaplasma, and chorioamnionitis was positively related to isolation. The presence of ureaplasmas in the placenta suggests the transcervical migration of these microorganisms from the lower genitourinary tract. These data show a strong association between ureaplasma infection of the placenta and low birth weight of the neonate and suggest that the association is causal.

Entities:  

Mesh:

Year:  1984        PMID: 6321990     DOI: 10.1056/NEJM198404123101502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  28 in total

Review 1.  The role of urogenital tract infections in the etiology of preterm birth: a review.

Authors:  J Martius; T Roos
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

Review 2.  Advances in medical diagnosis of intra-amniotic infection.

Authors:  Irina A Buhimschi; Unzila A Nayeri; Christine A Laky; Sonya-Abdel Razeq; Antonette T Dulay; Catalin S Buhimschi
Journal:  Expert Opin Med Diagn       Date:  2012-08-17

Review 3.  Maternal influences on fetal microbial colonization and immune development.

Authors:  Joann Romano-Keeler; Jörn-Hendrik Weitkamp
Journal:  Pediatr Res       Date:  2014-10-13       Impact factor: 3.756

Review 4.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

5.  Isolation of Mycoplasma species and Ureaplasma urealyticum from obstetrical and gynecological patients by using commercially available medium formulations.

Authors:  L E Phillips; K H Goodrich; R M Turner; S Faro
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Comparison of polymerase chain reaction assay with culture for detection of genital mycoplasmas in perinatal infections.

Authors:  N Luki; P Lebel; M Boucher; B Doray; J Turgeon; R Brousseau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

7.  The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants.

Authors:  Robert L Goldenberg; William W Andrews; Alice R Goepfert; Ona Faye-Petersen; Suzanne P Cliver; Waldemar A Carlo; John C Hauth
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

8.  The association between Chlamydia cervicitis, chorioamnionitis and neonatal complications.

Authors:  G G Donders; P Moerman; G H De Wet; P Hooft; P Goubau
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

9.  Genital mycoplasmas in preterm infants: prevalence and clinical significance.

Authors:  S Izraeli; Z Samra; L Sirota; P Merlob; S Davidson
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

10.  Detection of antibodies to Ureaplasma urealyticum in pregnant women by enzyme-linked immunosorbent assay using membrane antigen and investigation of the significance of the antibodies.

Authors:  M F Liepmann; P Wattre; A Dewilde; G Papierok; M Delecour
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.